The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, ...

Cosmos Health (COSM) announced the filing of a patent application for treatment for multiple sclerosis, a disabling autoimmune disorder ...

The patent application, filed under Application Number N2039644, represents a significant step forward in the Company's intellectual property strategy. This milestone highlights Cosmos Health's ...

Therefore, professionals usually reserve this treatment for cases where other multiple sclerosis treatment options, such as oral medications or physical therapy, have been ineffective. It is ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment ...

Columnist Ben Hofmeister, while searching for motivation in a life with multiple sclerosis, feels he just needs to get around to it.

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

Researchers have conducted one of the largest eye studies ever, revealing that retinal thickness could play a key role in ...

According to Grand View Research, the global multiple sclerosis treatment market has been experiencing steady growth, driven by advancements in therapeutic options and a rising prevalence of the ...